BAKER BROS ADVISORS LLC Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for May 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 15.47 | 37,520 | 580,434 | 37,520 | |
| May 31 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 15.47 | 37,520 | 580,434 | 37,520 | |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.77 | 22,720 | 2,743,928 | 7,382,978 | 7.4 M to 7.4 M (-0.31 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.77 | 2,729 | 329,585 | 952,874 | 955.6 K to 952.9 K (-0.29 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.31 | 13,213 | 1,616,054 | 7,405,698 | 7.4 M to 7.4 M (-0.18 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.31 | 1,587 | 194,103 | 955,603 | 957.2 K to 955.6 K (-0.17 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.12 | 15,355 | 1,844,459 | 7,418,911 | 7.4 M to 7.4 M (-0.21 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.12 | 1,845 | 221,623 | 957,190 | 959 K to 957.2 K (-0.19 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.37 | 35,796 | 4,380,432 | 7,434,266 | 7.5 M to 7.4 M (-0.48 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.37 | 4,300 | 526,200 | 959,035 | 963.3 K to 959 K (-0.45 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 123.06 | 30,766 | 3,786,036 | 7,470,062 | 7.5 M to 7.5 M (-0.41 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 123.06 | 3,696 | 454,826 | 963,335 | 967 K to 963.3 K (-0.38 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 121.37 | 39,732 | 4,822,189 | 7,500,828 | 7.5 M to 7.5 M (-0.53 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 121.37 | 4,772 | 579,168 | 967,031 | 971.8 K to 967 K (-0.49 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 127.06 | 71,819 | 9,125,258 | 7,540,560 | 7.6 M to 7.5 M (-0.94 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 127.06 | 8,627 | 1,096,139 | 971,803 | 980.4 K to 971.8 K (-0.88 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 125.05 | 22,886 | 2,861,901 | 7,612,379 | 7.6 M to 7.6 M (-0.30 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 125.05 | 2,749 | 343,763 | 980,430 | 983.2 K to 980.4 K (-0.28 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 126.25 | 15,541 | 1,962,085 | 7,635,265 | 7.7 M to 7.6 M (-0.20 %) |
| May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 126.25 | 1,867 | 235,713 | 983,179 | 985 K to 983.2 K (-0.19 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 45,842,649 | 45.8 M to 45.8 M (+0.01 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,963 | 0 | 5,304,837 | 5.3 M to 5.3 M (+0.06 %) |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 8.38 | 10,000 | 83,800 | 0 | |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 45,839,686 | 45.8 M to 45.8 M (+0.02 %) |
| May 01 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 8.38 | 10,000 | 83,800 | 5,301,874 | 5.3 M to 5.3 M (+0.19 %) |